<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02891356</url>
  </required_header>
  <id_info>
    <org_study_id>2011_38</org_study_id>
    <secondary_id>2012-A01009-34</secondary_id>
    <nct_id>NCT02891356</nct_id>
  </id_info>
  <brief_title>Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years</brief_title>
  <acronym>AMOS</acronym>
  <official_title>Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years and Relationship Between Bone Loss and Adipokines.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to
      play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines
      that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the
      relationship in anorexia nervosa patients with change in bone mineral density and adipokines
      like leptin, adiponectin and Préf-1 Bone mineral densities will be measure in 180 anorexia
      nervosa patients at inclusion and every two years during 6 years.It is assessed blood and
      urinary calcium and phosphate levels, bone remodelling markers and adipokines (leptin,
      adiponectin and Préf-1)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density by Dual Energy X-ray Absorptiometry (DEXA)</measure>
    <time_frame>4 years</time_frame>
    <description>measured the evolution of the bone mineral density in 180 anorexia nervosa patients and the relationship with this change and adipokine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of osteoporotic fractures</measure>
    <time_frame>at 2,4 and 6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adiponectin plasma concentration by ELISA</measure>
    <time_frame>at 2,4 and 6 years</time_frame>
    <description>measurement of circulating biological factors predicative of changes in BMD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-7 plasma concentration by ELISA</measure>
    <time_frame>at 2,4 and 6 years</time_frame>
    <description>measurement of circulating biological factors predicative of changes in BMD</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Anorexia patient</arm_group_label>
    <description>Dual Energy X-ray Absorptiometry (DEXA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DEXA</intervention_name>
    <description>The Dual Energy X-ray Absorptiometry (DEXA) is a third generation multi-captor DEXA device that allow short duration measurements. It measures Bone Mineral Density (BMD) at the spine and the femoral neck</description>
    <arm_group_label>Anorexia patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Anorexia patient recruted in psychiatric unit ( hospitalisation and consultation visit)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  anorexia patient defined by DSM IV diagnostic criteria

        Exclusion Criteria:

          -  patient with other psychiatric disease

          -  patient with other a metabolic bone disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle LEGROUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle LEGROUX, MD</last_name>
    <email>isabelle.legroux@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Roger Salengro, CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Isabelle LEGROUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2016</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adiponectin</keyword>
  <keyword>Bone remodelling markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

